Nationwide Rate of Adult ADHD Diagnosis and Pharmacotherapy from 2015 to 2018

There is a paucity of published literature on the epidemiology of adult attention-deficit/hyperactivity disorder (ADHD). We investigated the time trends of the diagnostic and pharmacotherapy incidence of ADHD, including the first used medication, in the adult population based on a Korean population-...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Sang-Min Lee, Hyeon-Kyoung Cheong, In-Hwan Oh, Minha Hong
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	adult attention deficit hyperactivity disorder diagnosis pharmacotherapy Medicine R
Acceso en línea:	https://doaj.org/article/affb734191b7486aab03c3655981beeb
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:affb734191b7486aab03c3655981beeb
record_format	dspace
spelling	oai:doaj.org-article:affb734191b7486aab03c3655981beeb2021-11-11T16:27:55ZNationwide Rate of Adult ADHD Diagnosis and Pharmacotherapy from 2015 to 201810.3390/ijerph1821113221660-46011661-7827https://doaj.org/article/affb734191b7486aab03c3655981beeb2021-10-01T00:00:00Zhttps://www.mdpi.com/1660-4601/18/21/11322https://doaj.org/toc/1661-7827https://doaj.org/toc/1660-4601There is a paucity of published literature on the epidemiology of adult attention-deficit/hyperactivity disorder (ADHD). We investigated the time trends of the diagnostic and pharmacotherapy incidence of ADHD, including the first used medication, in the adult population based on a Korean population-based database from 2015 to 2018. The number of diagnosed cases of ADHD significantly increased from 7782 in 2015 to 17,264 in 2018 (<i>p</i> = 0.03), which is 0.02% to 0.04% of the total population. Similarly, the number of pharmacotherapy cases of ADHD significantly increased from 3886 in 2015 to 12,502 in 2018 (<i>p</i> = 0.01), which is 0.01% to 0.03% of total population. The most commonly used medication at the initiation of pharmacotherapy shifted from Penid in 2015 to Concerta in 2018. Furthermore, combination therapy with two or more drugs was the preferred method in 2016–2018. In conclusion, the identified diagnoses and pharmacotherapy incidences were very low, highlighting the need to improve the public’s awareness of adult ADHD.Sang-Min LeeHyeon-Kyoung CheongIn-Hwan OhMinha HongMDPI AGarticleadultattention deficit hyperactivity disorderdiagnosispharmacotherapyMedicineRENInternational Journal of Environmental Research and Public Health, Vol 18, Iss 11322, p 11322 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	adult attention deficit hyperactivity disorder diagnosis pharmacotherapy Medicine R
spellingShingle	adult attention deficit hyperactivity disorder diagnosis pharmacotherapy Medicine R Sang-Min Lee Hyeon-Kyoung Cheong In-Hwan Oh Minha Hong Nationwide Rate of Adult ADHD Diagnosis and Pharmacotherapy from 2015 to 2018
description	There is a paucity of published literature on the epidemiology of adult attention-deficit/hyperactivity disorder (ADHD). We investigated the time trends of the diagnostic and pharmacotherapy incidence of ADHD, including the first used medication, in the adult population based on a Korean population-based database from 2015 to 2018. The number of diagnosed cases of ADHD significantly increased from 7782 in 2015 to 17,264 in 2018 (<i>p</i> = 0.03), which is 0.02% to 0.04% of the total population. Similarly, the number of pharmacotherapy cases of ADHD significantly increased from 3886 in 2015 to 12,502 in 2018 (<i>p</i> = 0.01), which is 0.01% to 0.03% of total population. The most commonly used medication at the initiation of pharmacotherapy shifted from Penid in 2015 to Concerta in 2018. Furthermore, combination therapy with two or more drugs was the preferred method in 2016–2018. In conclusion, the identified diagnoses and pharmacotherapy incidences were very low, highlighting the need to improve the public’s awareness of adult ADHD.
format	article
author	Sang-Min Lee Hyeon-Kyoung Cheong In-Hwan Oh Minha Hong
author_facet	Sang-Min Lee Hyeon-Kyoung Cheong In-Hwan Oh Minha Hong
author_sort	Sang-Min Lee
title	Nationwide Rate of Adult ADHD Diagnosis and Pharmacotherapy from 2015 to 2018
title_short	Nationwide Rate of Adult ADHD Diagnosis and Pharmacotherapy from 2015 to 2018
title_full	Nationwide Rate of Adult ADHD Diagnosis and Pharmacotherapy from 2015 to 2018
title_fullStr	Nationwide Rate of Adult ADHD Diagnosis and Pharmacotherapy from 2015 to 2018
title_full_unstemmed	Nationwide Rate of Adult ADHD Diagnosis and Pharmacotherapy from 2015 to 2018
title_sort	nationwide rate of adult adhd diagnosis and pharmacotherapy from 2015 to 2018
publisher	MDPI AG
publishDate	2021
url	https://doaj.org/article/affb734191b7486aab03c3655981beeb
work_keys_str_mv	AT sangminlee nationwiderateofadultadhddiagnosisandpharmacotherapyfrom2015to2018 AT hyeonkyoungcheong nationwiderateofadultadhddiagnosisandpharmacotherapyfrom2015to2018 AT inhwanoh nationwiderateofadultadhddiagnosisandpharmacotherapyfrom2015to2018 AT minhahong nationwiderateofadultadhddiagnosisandpharmacotherapyfrom2015to2018
_version_	1718432316013936640

Nationwide Rate of Adult ADHD Diagnosis and Pharmacotherapy from 2015 to 2018

Ejemplares similares